Vivus

8 Potential Biotech Acquisition Candidates
Seeking Alpha
Mon, 06/20/11 - 09:30 am
biotech
M&A
Arena Pharmaceuticals
Biomarin
Dendreon
Human Genome Sciences
Keryx
MannKind
Novartis
Orexigen
Vivus
3 Ways to Play Biotech With Options
Motley Fool
Tue, 06/14/11 - 08:05 pm
Amarin
SIGA technologies
Acorda Therapeutics
Orexigen
Vivus
FDA Bullies Obesity Drugmakers
Motley Fool
Sat, 06/4/11 - 10:06 am
Orexigen
Contrave
Vivus
Qnexa
Arena Pharmaceuticals
obesity
weight loss
Arena's New Data Doesn't Change Obesity Pill Outlook
Investopedia
Mon, 05/30/11 - 06:39 pm
obesity
Arena Pharmaceuticals
Human Genome Sciences
Dendreon
Orexigen
Vivus
Vanda
Arena, Orexigen and Vivus: An Update on Their Obesity Drugs
Seeking Alpha
Sat, 05/28/11 - 12:00 pm
Arena Pharmaceuticals
Orexigen
Vivus
obesity
Qnexa
weight loss
Contrave
Vivus readies NDA as Ph3 trial hits goals for ED drug
Fierce Biotech
Wed, 05/25/11 - 11:39 am
Vivus
erectile dysfunction
Avanafil
Diet-drug makers move into spotlight
MarketWatch
Sat, 05/21/11 - 10:44 am
Arena Pharmaceuticals
Vivus
Albany Molecular Research
Epilepsy Drug Study Showing Little Risk May Help Vivus Pill
Bloomberg
Tue, 05/17/11 - 08:53 pm
Vivus
epilepsy
Qnexa
Vivus Still Looking for Ways to Push Diet Drug Forward
Seeking Alpha
Mon, 05/9/11 - 09:19 am
Vivus
obesity
Qnexa
Vivus Puts Obesity Drug On A Diet
TheStreet.com
Tue, 05/3/11 - 09:02 am
Vivus
obesity
Qnexa
Vivus halves first-quarter loss
Bizjournals.com
Tue, 05/3/11 - 07:15 am
earnings
Vivus
What Vivus Fails To Say About Its Diet Pill Study
Pharmalot
Tue, 04/12/11 - 10:06 am
Vivus
Qnexa
obesity
Qnexa Trial Data is Good News for Vivus as Stock Rises
WSJ Online
Mon, 04/11/11 - 11:42 am
Qnexa
Vivus
obesity
Vivus shares Qnexa study data
Yahoo/AP
Mon, 04/4/11 - 09:29 am
obesity
Vivus
Qnexa
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Bloomberg
Fri, 03/4/11 - 10:40 am
Vivus
birth defects
Topamax
JNJ
Qnexa
Analyst Notes: Vivus delivers Qnexa update
Yahoo/AP
Tue, 03/1/11 - 11:33 am
Vivus
obesity
Qnexa
FDA Setbacks Make Vivus a Buying Opportunity
Seeking Alpha
Wed, 02/23/11 - 08:02 am
FDA
Vivus
Qnexa
obesity
Obesity Drugs: The Road to Perdition
TheStreet.com
Tue, 02/1/11 - 11:22 am
obesity
Orexigen
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Lorqess
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
A Foursome Of Pharma Earnings Suggests Business Is Still Tough
Investopedia
Mon, 01/31/11 - 05:07 pm
earnings
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
MannKind
Novartis
Vivus

Pages